| Beam Therapeutics operates as a biotechnology company. Through its subsidiaries, Co. is a research stage biotechnology company committed to creating a new class of precision genetic medicines, based on Co.'s proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases. We show 3 historical shares outstanding datapoints in our coverage of BEAM's shares outstanding history.|
Understanding the changing numbers of BEAM shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like BEAM versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching BEAM by allowing them to research BEAM shares outstanding history
as well as any other stock in our coverage universe.